This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Wernicke's encephalopathy

Authoring team

Wernicke's encephalopathy is a condition associated with alcohol abuse and other causes of thiamine deficiency.

It is characterised by acute capillary haemorrhages, astrocytosis and neuronal death in the upper brainstem and diencephalon that leads to:

  • an acute confusional state

  • ophthalmoplegia:
    • nystagmus
    • bilateral lateral rectus palsies
    • conjugate gaze palsies
    • fixed pupils
    • rarely papilloedema

  • ataxia:
    • broad based gait
    • cerebellar signs in the limbs
    • vestibular paralysis

Peripheral neuropathy, usually confined to the legs, occurs in the majority of cases. Most untreated patients proceed to develop a Korsakoff psychosis with loss of recent memory, disordered time appreciation, and confabulation.

Investigations reveal raised plasma pyruvate and reduced red cell transketolase.

Thiamine should be offered to people at high risk of developing, or with suspected, Wernicke's encephalopathy (1).

Parenteral thiamine should be offered to people with suspected Wernicke's encephalopathy (1)

  • maintain a high level of suspicion for the possibility of Wernicke's encephalopathy, especially if the person is intoxicated
  • parenteral treatment should be given for a minimum of 5 days, unless Wernicke's encephalopathy is excluded
  • oral thiamine treatment should follow parenteral therapy

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.